MilliporeSigma to make Elypta liquid biopsy kits

By The Science Advisory Board staff writers

February 18, 2020 -- MilliporeSigma has signed an agreement with Swedish molecular diagnostics company Elypta to be the contract manufacturer for Elypta's clinical diagnostic liquid biopsy kits.

Elypta's liquid biopsy kits analyze metabolites that are deregulated in several types of cancer, resulting in more accurate diagnoses, according to MilliporeSigma. The kits to be manufactured will use a biofluid sample to detect and analyze biological markers for cancer, enabling clinicians to diagnose patients and determine treatment options.

The kits will be made at MilliporeSigma's manufacturing plant in St. Louis and initially will be for research use only with mass spectrometry systems. The kits will allow researchers to measure the full spectrum of human glycosaminoglycans in samples of body fluid.

The contract manufacturing agreement with MilliporeSigma will allow Elypta to commercialize its test without a major investment in manufacturing and will get the product to market sooner. The firm expects to have research-use-only kits on the market in 2020.

Elypta plans to qualify the kits for use with in vitro diagnostic applications in the U.S. and the European Union after completing clinical validation studies; one study will evaluate the test for the surveillance of kidney cancer recurrence.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here